/
Oncology
Advanced Solid Cancer
3
Pipeline Programs↗
7
Active Trials↗
14
Companies Involved↗
Advanced Solid Cancer is an early-stage landscape with 3 programs across 14 companies. The most active players are Ascentage Pharma Group Inc., Minghui Pharmaceutical (Hangzhou) Ltd.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical1
Phase 2
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
21
clinical trials
Completed8 · 38%
Recruiting5 · 24%
Terminated4 · 19%
Unknown status2 · 10%
Active, not recruiting1 · 5%
Not yet recruiting1 · 5%
Clinical Trials
Trial Activity
21 trials
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)